HealthCap, a European venture capital firm investing exclusively in the life sciences, has backed and built more than 100 companies, taken more than 40 companies public and completed numerous trade sales. HealthCap’s portfolio businesses have developed over 25 pharmaceutical products to regulatory approval and have brought 50-plus medical device products to market.
Founding partner Björn Odlander and partner Mårten Steen spoke to In Vivo about the company’s strategy for building new biotechs,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?